Alfred M. Cohen, MD, FACS, FASCRS, Joins as Director, Cancer Biosignature Programs Alfred M. Cohen, MD, FACS, FASCRS, has joined Critical Path Institute (C-Path) as Director of its Cancer Biosignature Programs.
Martha Brumfield, PhD, Hired as Director, International Programs Martha Brumfield, PhD, has joined Critical Path Institute (C-Path) as Director of International Programs.
Leading Pharmacologist and Pharmaceutical Scientist Joins Critical Path Institute Thorir D. Bjornsson, MD, PhD, has joined Critical Path Institute as a member of its Board of Directors, and will also lead one of
Leading Neuroscientist Joins Critical Path Institute Marc Cantillon, MD, has joined Critical Path Institute as Executive Director of one of its major consortia, the Coalition Against
Manuscript on Current State of Pharmacometrics in Special Issue of Journal of Clinical Pharmacology Co-authored by C-Path’s Klaus Romero, MS, MD Recently Released Pharmacometrics as a Discipline Is Entering the “Industrialization” Phase: Standards, Automation, Knowledge Sharing, a
Raymond Woosley, MD, PhD, C-Path President/CEO to present keynote address at CDISC North American Exchange November 1-5, 2010 in Baltimore, MD The CDISC Board of Directors and Dr. Rebecca Kush, President & CEO are pleased to announce three exceptional keynote speakers
Governor Brewer Awards $2.2 Million in Stimulus Dollars Towards Creation of New Biomedical Research Resource in Arizona Science Foundation Arizona selects Tucson based Critical Path Institute and collaborator, Roche’s Ventana Medical Systems, t
January 9, 2010 Pharmacometrics As A Discipline Is Entering The “Industrialization” Phase: Standards, Automation, Knowledge Sharing, And Training Are Critical For Future Success